Old Web
English
Sign In
Acemap
>
Paper
>
Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience
Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience
2020
Gustavo Jiménez-Brítez
Pablo García Ruiz
Xavier Soler
Keywords:
Diabetes mellitus
Medicine
Single Center
Tocilizumab
Pathology
severe acute respiratory syndrome coronavirus 2
Coronavirus disease 2019
Internal medicine
2019 20 coronavirus outbreak
Correction
Source
Cite
Save
Machine Reading By IdeaReader
5
References
5
Citations
NaN
KQI
[]